Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2023 Volume 25 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2023 Volume 25 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway

  • Authors:
    • Xin Qian
    • Shijuan Xiong
    • Qi Chen
    • Jiaxing Zhang
    • Juan Xie
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550000, P.R. China
    Copyright: © Qian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 150
    |
    Published online on: February 16, 2023
       https://doi.org/10.3892/etm.2023.11850
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Parecoxib, a non‑steroidal anti‑inflammatory drug, has been reported to possess protective effects against sepsis. However, its detailed role and underlying mechanisms in septic cardiomyopathy remain unclear. Therefore, the goal of the present study was to clarify the function and to investigate the mechanisms of parecoxib in lipopolysaccharide (LPS)‑treated H9c2 rat cardiomyocytes. TNF‑α, IL‑1β and IL‑6 expression levels in parecoxib‑treated H9c2 cells stimulated with LPS were assessed using ELISA. Parecoxib‑treated H9c2 cells stimulated with LPS were tested for viability using the Cell Counting Kit‑8 assay. Western blotting analysis and 5‑ethynyl‑2'‑deoxyuridine were used to evaluate cell proliferation. Apoptosis was assessed using TUNEL and western blotting. To assess the protein expression of the MAPK signaling pathway, western blotting was performed. The data showed that parecoxib significantly and dose‑dependently reduced the inflammatory responses of LPS‑treated H9c2 cells. Parecoxib also significantly and dose‑dependently increased the proliferation and inhibited the apoptosis of LPS‑treated H9c2 cells. In addition, parecoxib significantly suppressed the activation of the MAPK (p38, JNK and ERK) signaling pathway. The current study indicated that parecoxib could be a viable therapeutic option for septic cardiomyopathy.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Salomão R, Ferreira BL, Salomão MC, Santos SS, Azevedo LCP and Brunialti MKC: Sepsis: Evolving concepts and challenges. Braz J Med Biol Res. 52(e8595)2019.PubMed/NCBI View Article : Google Scholar

2 

Candel FJ, Borges Sá M, Belda S, Bou G, Del Pozo JL, Estrada O, Ferrer R, González Del Castillo J, Julián-Jiménez A, Martín-Loeches I, et al: Current aspects in sepsis approach. Turning things around. Rev Esp Quimioter. 31:298–315. 2018.PubMed/NCBI

3 

Huang M, Cai S and Su J: The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 20(5376)2019.PubMed/NCBI View Article : Google Scholar

4 

van der Poll T, van de Veerdonk FL, Scicluna BP and Netea MG: The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 17:407–420. 2017.PubMed/NCBI View Article : Google Scholar

5 

Gotts JE and Matthay MA: Sepsis: Pathophysiology and clinical management. BMJ. 353(i1585)2016.PubMed/NCBI View Article : Google Scholar

6 

Fattahi F and Ward PA: Complement and sepsis-induced heart dysfunction. Mol Immunol. 84:57–64. 2017.PubMed/NCBI View Article : Google Scholar

7 

Shi X, Liu Y, Zhang D and Xiao D: Valproic acid attenuates sepsis-induced myocardial dysfunction in rats by accelerating autophagy through the PTEN/AKT/mTOR pathway. Life Sci. 232(116613)2019.PubMed/NCBI View Article : Google Scholar

8 

Li F, Lang F, Zhang H, Xu L, Wang Y, Zhai C and Hao E: Apigenin alleviates endotoxin-induced myocardial toxicity by modulating inflammation, oxidative stress, and autophagy. Oxid Med Cell Longev. 2017(2302896)2017.PubMed/NCBI View Article : Google Scholar

9 

Lado-Abeal J, Martinez-Sánchez N, Cocho JA, Martín-Pastor M, Castro-Piedras I, Couce-Pico ML, Saha AK and López M: Lipopolysaccharide (LPS)-induced septic shock causes profound changes in myocardial energy metabolites in pigs. Metabolomics. 14(131)2018.PubMed/NCBI View Article : Google Scholar

10 

Hsu WT, Galm BP, Schrank G, Hsu TC, Lee SH, Park JY and Lee CC: Effect of renin-angiotensin-aldosterone system inhibitors on short-term mortality after sepsis: A population-based cohort study. Hypertension. 75:483–491. 2020.PubMed/NCBI View Article : Google Scholar

11 

Wang SM, Liu GQ, Xian HB, Si JL, Qi SX and Yu YP: LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-κB signaling pathway. Eur Rev Med Pharmacol Sci. 23:4898–4907. 2019.PubMed/NCBI View Article : Google Scholar

12 

Wu H, Liu J, Li W, Liu G and Li Z: LncRNA-HOTAIR promotes TNF-α production in cardiomyocytes of LPS-induced sepsis mice by activating NF-κB pathway. Biochem Biophys Res Commun. 471:240–246. 2016.PubMed/NCBI View Article : Google Scholar

13 

Sun LJ, Qiao W, Xiao YJ, Cui L, Wang X and Ren WD: Naringin mitigates myocardial strain and the inflammatory response in sepsis-induced myocardial dysfunction through regulation of PI3K/AKT/NF-κB pathway. Int Immunopharmacol. 75(105782)2019.PubMed/NCBI View Article : Google Scholar

14 

Han D, Li X, Li S, Su T, Fan L, Fan WS, Qiao HY, Chen JW, Fan MM, Li XJ, et al: Reduced silent information regulator 1 signaling exacerbates sepsis-induced myocardial injury and mitigates the protective effect of a liver X receptor agonist. Free Radic Biol Med. 113:291–303. 2017.PubMed/NCBI View Article : Google Scholar

15 

Essex MN, Xu H, Parsons B, Xie L and Li C: Parecoxib relieves pain and has an opioid-sparing effect following major gastrointestinal surgery. Int J Gen Med. 10:319–327. 2017.PubMed/NCBI View Article : Google Scholar

16 

Ling Y, Chen J, Tao M, Chu X and Zhang X: A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma. J Thorac Dis. 4:58–62. 2012.PubMed/NCBI View Article : Google Scholar

17 

Tan JH, Zhou L, Kan HP and Zhang GW: Parecoxib improves the outcomes of acute mild and moderate pancreatitis: A 3-year matched cohort study based on a prospective database. Pancreas. 48:1148–1154. 2019.PubMed/NCBI View Article : Google Scholar

18 

Eberstål S, Badn W, Fritzell S, Esbjörnsson M, Darabi A, Visse E and Siesjö P: Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors. Cancer Immunol Immunother. 61:1191–1199. 2012.PubMed/NCBI View Article : Google Scholar

19 

Chen J, Cong X, Zhan X, Zhou Z and Zheng W: Effects of parecoxib on pain threshold and inflammatory factors IL-1β, IL-6 and TNF-α in spinal cord of rats with bone cancer pain. J Coll Physicians Surg Pak. 29:528–531. 2019.PubMed/NCBI View Article : Google Scholar

20 

Zhang J, Wang L, Xie W, Hu S, Zhou H, Zhu P and Zhu H: Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK-ERK pathway. J Cell Physiol. 235:2847–2856. 2020.PubMed/NCBI View Article : Google Scholar

21 

Chen Z, Cao Z, Gui F, Zhang M, Wu X, Peng H, Yu B, Li W, Ai F and Zhang J: TMEM43 protects against sepsis-induced cardiac injury via inhibiting ferroptosis in mice. Cells. 11(2992)2022.PubMed/NCBI View Article : Google Scholar

22 

Huang Y, Zhang N, Xie C, You Y, Guo L, Ye F, Xie X and Wang J: Lipocalin-2 in neutrophils induces ferroptosis in septic cardiac dysfunction via increasing labile iron pool of cardiomyocytes. Front Cardiovasc Med. 9(922534)2022.PubMed/NCBI View Article : Google Scholar

23 

Lei S, Zhang Y, Su W, Zhou L, Xu J and Xia ZY: Remifentanil attenuates lipopolysaccharide-induced oxidative injury by downregulating PKCβ2 activation and inhibiting autophagy in H9C2 cardiomyocytes. Life Sci. 213:109–115. 2018.PubMed/NCBI View Article : Google Scholar

24 

Zhang WX, He BM, Wu Y, Qiao JF and Peng ZY: Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice. Life Sci. 217:8–15. 2019.PubMed/NCBI View Article : Google Scholar

25 

Alvarez S, Vico T and Vanasco V: Cardiac dysfunction, mitochondrial architecture, energy production, and inflammatory pathways: Interrelated aspects in endotoxemia and sepsis. Int J Biochem Cell Biol. 81:307–314. 2016.PubMed/NCBI View Article : Google Scholar

26 

Chen H, Wang X, Yan X, Cheng X, He X and Zheng W: RETRACTED: LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB. Int Immunopharmacol. 55:69–76. 2018.PubMed/NCBI View Article : Google Scholar

27 

Wang Z, Bu L, Yang P, Feng S and Xu F: Alleviation of sepsis-induced cardiac dysfunction by overexpression of Sestrin2 is associated with inhibition of p-S6K and activation of the p-AMPK pathway. Mol Med Rep. 20:2511–2518. 2019.PubMed/NCBI View Article : Google Scholar

28 

Yücel G, Zhao Z, El-Battrawy I, Lan H, Lang S, Li X, Buljubasic F, Zimmermann WH, Cyganek L, Utikal J, et al: Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes. Sci Rep. 7(2935)2017.PubMed/NCBI View Article : Google Scholar

29 

Muller-Werdan U, Buerke M, Ebelt H, Heinroth KM, Herklotz A, Loppnow H, Ruß M, Schlegel F, Schlitt A, Schmidt HB, et al: Septic cardiomyopathy-a not yet discovered cardiomyopathy? Exp Clin Cardiol. 11:226–236. 2006.PubMed/NCBI

30 

Zhou N, Zeng MN, Li K, Yang YY, Bai ZY, Zheng XK and Feng WS: An integrated metabolomic strategy for the characterization of the effects of Chinese yam and its three active components on septic cardiomyopathy. Food Funct. 9:4989–4997. 2018.PubMed/NCBI View Article : Google Scholar

31 

Shang X, Lin K, Yu R, Zhu P, Zhang Y, Wang L, Xu J and Chen K: Resveratrol protects the myocardium in sepsis by activating the phosphatidylinositol 3-kinases (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway and inhibiting the nuclear factor-κB (NF-κB) signaling pathway. Med Sci Monit. 25:9290–9298. 2019.PubMed/NCBI View Article : Google Scholar

32 

Buerke U, Carter JM, Schlitt A, Russ M, Schmidt H, Sibelius U, Grandel U, Grimminger F, Seeger W, Mueller-Werdan U, et al: Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock. 29:497–503. 2008.PubMed/NCBI View Article : Google Scholar

33 

Lancel S, Joulin O, Favory R, Goossens JF, Kluza J, Chopin C, Formstecher P, Marchetti P and Neviere R: Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation. 111:2596–2604. 2005.PubMed/NCBI View Article : Google Scholar

34 

Zhou R, Yang X, Li X, Qu Y, Huang Q, Sun X and Mu D: Recombinant CC16 inhibits NLRP3/caspase-1-induced pyroptosis through p38 MAPK and ERK signaling pathways in the brain of a neonatal rat model with sepsis. J Neuroinflammation. 16(239)2019.PubMed/NCBI View Article : Google Scholar

35 

Zhang FL, Zhou BW, Yan ZZ, Zhao J, Zhao BC, Liu WF, Li C and Liu KX: 6-Gingerol attenuates macrophages pyroptosis via the inhibition of MAPK signaling pathways and predicts a good prognosis in sepsis. Cytokine. 125(154854)2020.PubMed/NCBI View Article : Google Scholar

36 

Koch L, Frommhold D, Buschmann K, Kuss N, Poeschl J and Ruef P: LPS- and LTA-induced expression of IL-6 and TNF-α in neonatal and adult blood: Role of MAPKs and NF-κB. Mediators Inflamm. 2014(283126)2014.PubMed/NCBI View Article : Google Scholar

37 

Yego ECK and Dillman JF III: Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard. Toxicol In Vitro. 27:2067–2075. 2013.PubMed/NCBI View Article : Google Scholar

38 

Luo Y, Che W and Zhao M: Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells. Int J Mol Med. 39:297–306. 2017.PubMed/NCBI View Article : Google Scholar

39 

Tien YC, Lin JY, Lai CH, Kuo CH, Lin WY, Tsai CH, Tsai FJ, Cheng YC, Peng WH and Huang CY: 9Carthamus tinctorius L. prevents LPS-induced TNFalpha signaling activation and cell apoptosis through JNK1/2-NFkappaB pathway inhibition in H9c2 cardiomyoblast cells. J Ethnopharmacol. 130:505–513. 2010.PubMed/NCBI View Article : Google Scholar

40 

Li M, Ye J, Zhao G, Hong G, Hu X, Cao K, Wu Y and Lu Z: Gas6 attenuates lipopolysaccharide-induced TNF-α expression and apoptosis in H9C2 cells through NF-κB and MAPK inhibition via the Axl/PI3K/Akt pathway. Int J Mol Med. 44:982–994. 2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Qian X, Xiong S, Chen Q, Zhang J and Xie J: Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway. Exp Ther Med 25: 150, 2023.
APA
Qian, X., Xiong, S., Chen, Q., Zhang, J., & Xie, J. (2023). Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway. Experimental and Therapeutic Medicine, 25, 150. https://doi.org/10.3892/etm.2023.11850
MLA
Qian, X., Xiong, S., Chen, Q., Zhang, J., Xie, J."Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway". Experimental and Therapeutic Medicine 25.4 (2023): 150.
Chicago
Qian, X., Xiong, S., Chen, Q., Zhang, J., Xie, J."Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway". Experimental and Therapeutic Medicine 25, no. 4 (2023): 150. https://doi.org/10.3892/etm.2023.11850
Copy and paste a formatted citation
x
Spandidos Publications style
Qian X, Xiong S, Chen Q, Zhang J and Xie J: Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway. Exp Ther Med 25: 150, 2023.
APA
Qian, X., Xiong, S., Chen, Q., Zhang, J., & Xie, J. (2023). Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway. Experimental and Therapeutic Medicine, 25, 150. https://doi.org/10.3892/etm.2023.11850
MLA
Qian, X., Xiong, S., Chen, Q., Zhang, J., Xie, J."Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway". Experimental and Therapeutic Medicine 25.4 (2023): 150.
Chicago
Qian, X., Xiong, S., Chen, Q., Zhang, J., Xie, J."Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway". Experimental and Therapeutic Medicine 25, no. 4 (2023): 150. https://doi.org/10.3892/etm.2023.11850
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team